Ursachen, Diagnostik und Behandlung der Malassimilation

Abstract

Patients with malassimilation suffer from disturbed exploitation of available nutrients, which can affect macro- and micronutrients. Malassimilation can be subdivided in maldigestion and malabsorption. Many different disorders, especially gastrointestinal diseases, can lead to malassimilation. The wide variety of differential diagnoses necessitates big diagnostic as well as financial efforts in order to assure good clinical care. This review provides an overview on diagnostic as well as therapeutic processes of patients with malassimilation and gives practical advice for their physicians and therapists.

Bei einer Malassimilation liegt eine gestörte Nahrungsmittelaufnahme vor, die Makro- und Mikronährstoffe betreffen kann. Daraus resultieren zahlreiche verschiedene internistische Krankheitsbilder. Die große Anzahl an Differenzialdiagnosen stellt eine große Herausforderung für den behandelnden Arzt dar. Dieser Übersichtsartikel hat zum Ziel, alltagstaugliche Hinweise für die Versorgung entsprechender Patienten zu liefern.

Schlüsselwörter

Malassimilation - Malabsorption - Maldigestion - Mangelernährung

Key words

malassimilation - malabsorption - maldigestion - malnutrition

• Literatur

• 1 Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part II: laboratory evaluation. Nutrition 2000; 16: 131-140
• 2 Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools. Nutrition 2000; 16: 50-63
• 3 Schulzke JD, Tröger H, Amasheh M. Disorders of intestinal secretion and absorption. Best Pract Res Clin Gastroenterol 2009; 23: 395-406
• 4 Hollenbach M, Hoffmeister A, Rosendahl J. et al. [Importance of functional diagnostics in gastroenterology]. Internist (Berl) 2018; 59: 25-37 doi:10.1007/s00108-017-0359-0
• 5 Mössner J, Keim V. Pancreatic enzyme therapy. Dtsch Arztebl Int 2010; 108: 578-582 doi:10.3238/arztebl.2011.0578
• 6 Raithel M, Weidenhiller M, Hagel AF. et al. The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnoses. Dtsch Arztebl Int 2013; 110: 775-782 doi:10.3238/arztebl.2013.0775
• 7 Grace E, Shaw C, Whelan K. et al. Review article: Small intestinal bacterial overgrowth – Prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013; 38: 674-688 doi:10.1111/apt.12456
• 8 Kamp A, Schäfer C. Ernährungstherapie bei Kohlenhydratunverträglichkeiten. Ernährung Medizin 2009; 24: 24-27 doi:10.1055/s-0029-1213464
• 9 Montalto M, Gallo A, Ojetti V. et al. Fructose, trehalose and sorbitol malabsorption. Eur Rev Med Pharmacol Sci 2013; 17 (Suppl. 02) 26-29
• 10 Schäfer C. Fruktose: Malabsorption oder Intoleranz? Strategien für die Ernährungstherapie. Ernährungs Umschau 2009; 56: 694-700
• 11 Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet 2017; 6736: 1-12 doi:10.1016/S0140-6736(17)31796-8
• 12 Mustalahti K, Catassi C, Reunanen A. et al. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 2010; 42: 587-595 doi:10.3109/07853890.2010.505931
• 13 Felber J, Aust D, Baas S. et al. Ergebnisse einer S2k-Konsensuskonferenz der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS) gemeinsam mit der Deutschen Zöliakie-Gesellschaft (DZG) zur Zöliakie, Weizenallergie und Weizensensitivität. Z Gastroenterol 2014; 52: 711-743
• 14 Hall NJ, Rubin GP, Charnock A. Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey. Appetite 2013; 68: 56-62 doi:10.1016/j.appet.2013.04.016
• 15 Rubio-Tapia A, Hill ID, Kelly CP. et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108: 656-676 . doi:10.1038/ajg.2013.79
• 16 DeGaetani M, Tennyson CA, Lebwohl B. et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 2013; 108: 647-653 doi:10.1038/ajg.2013.45
• 17 Seetharam P, Rodrigues G. Short bowel syndrome: a review of management options. Saudi J Gastroenterol 17: 229-235 doi:10.4103/1319-3767
• 18 Tee CT, Wallis K, Gabe SM. Emerging treatment options for short bowel syndrome: potential role of teduglutide. Clin Exp Gastroenterol 2011; 4: 189-196 doi:10.2147/CEG.S13906
• 19 Corazza GR, Di Stefano M, Scarpignato C. Treatment of functional bowel disorders: is there room for antibiotics?. Digestion 2006; 73 (Suppl. 01) 38-46 doi:10.1159/000089778
• 20 Shah SC, Day LW, Somsouk M. et al. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2013; 38: 925-934 doi:10.1111/apt.12479
• 21 Grace E, Shaw C, Whelan K. et al. Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013; 38: 674-688 doi:10.1111/apt.12456
• 22 Acosta A, Camilleri M, Shin A. et al. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e173 doi: 10.1038/ctg.2016.32